Follicle Stimulating Hormone Market Key Players, Industry Overview, Supply Chain And Analysis To 2019-2025

0
28
Want create site? Find Free WordPress Themes and plugins.

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Scope of the Report:
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). It is mainly used to treat infertility disease and assisted reproductive technology. At present, this product cannot be replaced in the treatment of infertility.
Currently, There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are top two companies in the world. In 2016, Merck Serono takes about 58.70% of global follicle stimulating hormone revenue. MSD takes about 26.29% of global follicle stimulating hormone revenue.
The worldwide market for Follicle Stimulating Hormone is expected to grow at a CAGR of roughly 3.7% over the next five years, will reach 1550 million US$ in 2024, from 1250 million US$ in 2019, according to a new Research study.
This report focuses on the Follicle Stimulating Hormone in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Get a FREE sample Copy of this report : https://www.1marketresearch.com/market-reports/follicle-stimulating-hormone-market-industry-report-115876#requestSample

Market Segment by Manufacturers, this report covers

Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva

Browse Report :https://www.1marketresearch.com/market-reports/follicle-stimulating-hormone-market-industry-report-115876

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Recombinant FSH
Urinary FSH

Market Segment by Applications, can be divided into
Infertility Treatment
Assisted Reproductive Technology

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Follicle Stimulating Hormone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Follicle Stimulating Hormone, with price, sales, revenue and global market share of Follicle Stimulating Hormone in 2017 and 2018.
Chapter 3, the Follicle Stimulating Hormone competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Follicle Stimulating Hormone breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Follicle Stimulating Hormone market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Follicle Stimulating Hormone sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Did you find apk for android? You can find new Free Android Games and apps.